These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17452407)

  • 1. Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients.
    Kato S; Lindholm B; Axelsson J; Qureshi RA; Barany P; Heimbürger O; Gustafsson JA; Stenvinkel P; Nordfors L
    Nephrol Dial Transplant; 2007 Sep; 22(9):2571-7. PubMed ID: 17452407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis.
    Kjaergaard AD; Ellervik C; Tybjaerg-Hansen A; Axelsson CK; Grønholdt ML; Grande P; Jensen GB; Nordestgaard BG
    Circulation; 2007 Feb; 115(7):861-71. PubMed ID: 17309937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
    Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
    Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
    Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
    Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
    Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy.
    Yao Q; Nordfors L; Axelsson J; Heimbürger O; Qureshi AR; Báràny P; Lindholm B; Lönnqvist F; Schalling M; Stenvinkel P
    Atherosclerosis; 2005 Sep; 182(1):105-11. PubMed ID: 16115480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.
    Rapuri PB; Gallagher JC; Knezetic JA; Haynatzka V
    Maturitas; 2006 Mar; 53(4):371-9. PubMed ID: 16139450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 gene cluster polymorphisms are associated with nutritional status and inflammation in patients with end-stage renal disease.
    Maruyama Y; Nordfors L; Stenvinkel P; Heimburger O; Bárány P; Pecoits-Filho R; Axelsson J; Hoff CM; Holmes CJ; Schalling M; Lindholm B
    Blood Purif; 2005; 23(5):384-93. PubMed ID: 16088107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid profile and inflammatory markers associated with estrogen receptor alpha PvuII and XbaI gene polymorphisms.
    Boroumand M; Ghaedi M; Mohammadtaghvaei N; Pourgholi L; Anvari MS; Davoodi G; Amirzadegan A; Saadat S; Sheikhfathollahi M; Goodarzynejad H
    Transl Res; 2009 Jun; 153(6):288-95. PubMed ID: 19446283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
    Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study.
    Jamison RL; Shih MC; Humphries DE; Guarino PD; Kaufman JS; Goldfarb DS; Warren SR; Gaziano JM; Lavori P;
    Am J Kidney Dis; 2009 May; 53(5):779-89. PubMed ID: 19272686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogen receptor {alpha} gene polymorphisms in systemic lupus erythematosus.
    Johansson M; Arlestig L; Möller B; Smedby T; Rantapää-Dahlqvist S
    Ann Rheum Dis; 2005 Nov; 64(11):1611-7. PubMed ID: 15817658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients.
    Brezzi B; Del Prete D; Lupo A; Magistroni R; Gomez-Lira M; Bernich P; Anglani F; Mezzabotta F; Turco A; Furci L; Ceol M; Antonucci F; Abaterusso C; Bonfante L; D'Angelo A; Albertazzi A; Gambaro G
    J Nephrol; 2009; 22(6):747-59. PubMed ID: 19967654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor alpha gene polymorphism associated with type 2 diabetes mellitus and the serum lipid concentration in Chinese women in Guangzhou.
    Huang Q; Wang TH; Lu WS; Mu PW; Yang YF; Liang WW; Li CX; Lin GP
    Chin Med J (Engl); 2006 Nov; 119(21):1794-801. PubMed ID: 17097034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.
    Aker S; Bantis C; Reis P; Kuhr N; Schwandt C; Grabensee B; Heering P; Ivens K
    Nephrol Dial Transplant; 2009 Sep; 24(9):2847-51. PubMed ID: 19349293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients.
    Altun B; Yilmaz R; Kahraman S; Gençtoy G; Arici M; Onalan O; Oto A; Hayran M; Bakkaloğlu M; Yasavul U; Turgan C
    Transpl Int; 2005 Jun; 18(6):681-9. PubMed ID: 15910294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between estrogen receptor alpha (ESR1) gene polymorphisms and severe preeclampsia.
    Molvarec A; Vér A; Fekete A; Rosta K; Derzbach L; Derzsy Z; Karádi I; Rigó J
    Hypertens Res; 2007 Mar; 30(3):205-11. PubMed ID: 17510501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
    Shen Y; Li DK; Wu J; Zhang Z; Gao E
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of non-HLA genetic variants in end-stage renal disease.
    Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
    Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of parathyroid tissue calcium sensing receptor gene polymorphisms and expression levels in end-stage renal disease patients.
    Eren PA; Turan K; Berber I; Canbakan M; Kara M; Tellioglu G; Bugan U; Sevinç C; Turkmen F; Titiz MI
    Clin Nephrol; 2009 Aug; 72(2):114-21. PubMed ID: 19640368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.